US EditionPublished • loading... • Updated
Ann Arbor Residents Grapple with ADHD Medication Shortages
Summary by The Michigan Daily
2 Articles
2 Articles
FDA Issues Recall for ADHD Medication.
PULSE POINTSWHAT HAPPENED: Sun Pharmaceutical Industries issued a voluntary recall of several lots of lisdexamfetamine dimesylate capsules due to a quality control defect.WHO WAS INVOLVED: Sun Pharmaceutical Industries, the Food and Drug Administration (FDA), and millions of Americans on attention-deficit hyperactivity disorder (ADHD) medication.WHEN & WHERE: The recall affects capsules with expiration dates ranging from February 2026 to May 202…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
